C16H17N9O5S3.0.5HCl
Neat
511.55 0.5 36.46
-20°C
Room Temperature
Cefmenoxime hydrochloride; 75738-58-8; Cefmenoxime HCl; Cefmax; Cefmenoxime hemihydrochloride; Tacef; Abbott-50192; NON736D32W; DTXSID0046646; SCE-1365 HYDROCHLORIDE; NSC-760352; DTXCID8026646; CHEBI:31370; Abbott50192; RefChem:57261; Hydrochloride, Cefmenoxime; Cefmenoxime Hydrochloride (2:1); (6R and 7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetylamino)-3-(1-methyl-1H-tetrazol-5-ylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid hemihydrochloride; MFCD01750403; ABBOTT-50192 (HCL)
bis((6R, 7R)-7-[[(2Z)-2-(2-amino-1 and 3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid);hydrochloride
InChI=1S/2C16H17N9O5S3.ClH/c2*1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7;/h2*5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29);1H/b2*21-8-;/t2*9-,13-;/m11./s1